- Filed
- Jan 4, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2019 · Jan 2, 2019 | 176.76M sh |
| Shares Diluted | Q3 2019 · Nov 30, 2018 | 186.06M sh |
| Shares Diluted | Q3 2019 · Nov 30, 2018 | 187.5M sh |
| Shares Diluted | Q3 2019 · Nov 30, 2017 | 186.16M sh |
| Shares Diluted | Q3 2019 · Nov 30, 2017 | 183.4M sh |
| Stock Repurchased | Q3 2019 · Nov 30, 2018 | $12.79M |
| Stock Repurchased | Q3 2019 · Nov 30, 2018 | $412.85M |
| Stock Repurchased | Q3 2019 · Nov 30, 2017 | $100M |
| Stock Repurchased | Q3 2019 · Nov 30, 2017 | $237M |
| Capex | Q3 2019 · Nov 30, 2018 | $18.23M |
| Capex | Q3 2019 · Nov 30, 2018 | $44.85M |
| Capex | Q3 2019 · Nov 30, 2017 | $16.59M |
| Capex | Q3 2019 · Nov 30, 2017 | $68.27M |
| Operating Cash Flow | Q3 2019 · Nov 30, 2018 | $136.73M |
| Operating Cash Flow | Q3 2019 · Nov 30, 2018 | $615.68M |
| Operating Cash Flow | Q3 2019 · Nov 30, 2017 | $160.31M |
| Operating Cash Flow | Q3 2019 · Nov 30, 2017 | $561.08M |
| Short Term Investments | Q3 2019 · Nov 30, 2018 | $387.89M |
| Short Term Investments | Q3 2019 · Feb 28, 2018 | $318.36M |
| Stockholders Equity | Q3 2019 · Nov 30, 2018 | $1.42B |
| Stockholders Equity | Q3 2019 · Aug 31, 2018 | $1.29B |
| Stockholders Equity | Q3 2019 · Feb 28, 2018 | $1.48B |
| Stockholders Equity restated | Q3 2019 · Nov 30, 2017 | $1.44B |
| Stockholders Equity restated | Q3 2019 · Aug 31, 2017 | $1.41B |
| Stockholders Equity restated | Q3 2019 · Feb 28, 2017 | $1.25B |
| Current Liabilities | Q3 2019 · Nov 30, 2018 | $2.36B |
| Current Liabilities | Q3 2019 · Feb 28, 2018 | $2.31B |
| Current Assets | Q3 2019 · Nov 30, 2018 | $2.97B |
| Current Assets | Q3 2019 · Feb 28, 2018 | $3.14B |
| Total Assets | Q3 2019 · Nov 30, 2018 | $5.1B |
| Total Assets | Q3 2019 · Feb 28, 2018 | $5.47B |
| Total Assets restated | Q3 2019 · Nov 30, 2017 | $4.77B |
| Eps Diluted | Q3 2019 · Nov 30, 2018 | $0.51 |
| Eps Diluted | Q3 2019 · Nov 30, 2018 | $1.57 |
| Eps Diluted restated | Q3 2019 · Nov 30, 2017 | $0.55 |
| Eps Diluted restated | Q3 2019 · Nov 30, 2017 | $1.49 |
| Eps Basic | Q3 2019 · Nov 30, 2018 | $0.54 |
| Eps Basic | Q3 2019 · Nov 30, 2018 | $1.67 |
| Eps Basic | Q3 2019 · Nov 30, 2017 | $0.57 |
| Eps Basic restated | Q3 2019 · Nov 30, 2017 | $1.55 |
| Sga Expense | Q3 2019 · Nov 30, 2018 | $95.86M |
| Sga Expense | Q3 2019 · Nov 30, 2018 | $227.79M |
| Sga Expense | Q3 2019 · Nov 30, 2017 | $63.84M |
| Sga Expense | Q3 2019 · Nov 30, 2017 | $180.43M |
| Rd Expense | Q3 2019 · Nov 30, 2018 | $164.27M |
| Rd Expense | Q3 2019 · Nov 30, 2018 | $497.08M |
| Rd Expense | Q3 2019 · Nov 30, 2017 | $145.58M |
| Rd Expense | Q3 2019 · Nov 30, 2017 | $424.55M |
| Net Income | Q3 2019 · Nov 30, 2018 | $94.45M |
| Net Income | Q3 2019 · Nov 30, 2018 | $294.49M |
| Net Income restated | Q3 2019 · Nov 30, 2017 | $101.61M |
| Net Income restated | Q3 2019 · Nov 30, 2017 | $274.01M |
| Operating Income | Q3 2019 · Nov 30, 2018 | $108.96M |
| Operating Income | Q3 2019 · Nov 30, 2018 | $355.67M |
| Operating Income restated | Q3 2019 · Nov 30, 2017 | $118.72M |
| Operating Income restated | Q3 2019 · Nov 30, 2017 | $343.25M |
| Gross Profit | Q3 2019 · Nov 30, 2018 | $722.68M |
| Gross Profit | Q3 2019 · Nov 30, 2018 | $2.12B |
| Gross Profit | Q3 2019 · Nov 30, 2017 | $636.22M |
| Gross Profit | Q3 2019 · Nov 30, 2017 | $1.83B |
| Revenue | Q3 2019 · Nov 30, 2018 | $846.8M |
| Revenue | Q3 2019 · Nov 30, 2018 | $2.48B |
| Revenue | Q3 2019 · Nov 30, 2017 | $747.98M |
| Revenue | Q3 2019 · Nov 30, 2017 | $2.15B |